Switzerland
Tuberculosis profile
Population  2013 8.1 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.017 (0.017–0.017) 0.21 (0.21–0.21)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.02 (0.01–0.04)
Prevalence  (includes HIV+TB) 0.65 (0.25–1.2) 8 (3.2–15)
Incidence  (includes HIV+TB) 0.53 (0.5–0.58) 6.5 (6.1–7.2)
Incidence (HIV+TB only) 0.011 (0.01–0.026) 0.13 (0.12–0.33)
Case detection, all forms (%) 88 (80–94)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 1.5 (0.32–4.4) 24 (11–41)
MDR-TB cases among notified pulmonary
TB cases
5 (1–14) 14 (6–25)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 280    
Pulmonary, clinically diagnosed 40    
Extrapulmonary 146    
       
Total new and relapse 466    
Previously treated, excluding relapses 60    
Total cases notified 526    
Among 466 new cases:
22 (5%) cases aged under 15 years; male:female ratio: 1.0
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 269 (96%) 44 (73%) 416
Laboratory-confirmed RR-/MDR-TB cases     16
Patients started on MDR-TB treatment     0
TB/HIV 2013 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New cases registered in 2012  
Previously treated cases registered in 2012  
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions) 3
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-05-30 Data: www.who.int/tb/data